The thing with them getting financing is they have actual products that the financiers can see and run numbers on, $25-$50 million is nothing to them when they can see a 10x plus ROI. You have these drug companies with $1 million monthly burn rates that the drugs can end up not getting FDA approval and they are out millions from the backing. I think they are in good shape, a 830am spot Thursday as the only OTC presenting? What's that tell you..
News 
Market Data 
Discover 
AI
